SCHEMBL29544663

SCHEMBL29544663

CC(C)(C)OC(=O)Nc1cc2c(-c3nn4c(c3Cl)C(=O)NCC4)ccnc2cn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK3 Q9Y572 3/20 0.36
GSK3B P49841 1/20 0.35
DYRK1A Q13627 1/20 0.35
TGFBR1 P36897 2/20 0.35
AAK1 Q2M2I8 7/20 0.35
IRAK4 Q9NWZ3 1/20 0.34
CDK9 P50750 2/20 0.33
RORC P51449 1/20 0.33
ATR Q13535 1/20 0.32
PIK3CD O00329 1/20 0.32
ABL1 P00519 1/20 0.32
EGFR P00533 1/20 0.32
HCK P08631 1/20 0.32
SRC P12931 1/20 0.32
KDR P35968 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
MTOR P42345 1/20 0.32
PIK3CG P48736 1/20 0.32
EPHB4 P54760 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29544495 0.86 GSK3B (0.35) GSK3BDYRK1ATGFBR1AAK1IRAK4
SCHEMBL29544745 0.84 TYK2 (0.36) RIPK3TGFBR1IRAK4CDK9RORC
SCHEMBL29544758 0.82 EGFR (0.39) RIPK3TGFBR1CDK9RORCEGFR
SCHEMBL29545167 0.79 PIK3CA (0.32) GSK3BTGFBR1PIK3CAMTOR
SCHEMBL29544451 0.76 BUB1 (0.33)
SCHEMBL29544631 0.76 TGFBR1 (0.46) RIPK3GSK3BDYRK1ATGFBR1AAK1
SCHEMBL29545042 0.74 PIM1 (0.36) CDK9EGFRSRCKDR
SCHEMBL29545041 0.74 PIM1 (0.36) CDK9EGFRSRCKDR
SCHEMBL29544561 0.73 MET (0.34) TGFBR1PIK3CAMTOR
SCHEMBL29544753 0.73 CCNC (0.36) DYRK1ATGFBR1MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022072634-A1 BICYCLIC COMPOUNDS FOR USE IN THE TREATMENT CANCER SCORPION THERAPEUTICS, INC. (US) 2022-04-07 WO disclosed